Article Published: October 21, 2016
Article Published: October 21, 2016
The latest headlines from Pittsburgh Technology Council members, including Project Execution Network, Data Science Automation and Cernostics.
On October 9, 2016, cruise missiles were fired from Yemen at the USS Mason and the USS Ponce. The attacks were nullified by the U.S. defense systems that included Sea Sparrow missiles. On Thursday morning, October 14, 2016, the US Navy fired Tomahawk missiles destroying three radar sites within Yemen.
Data Science Automation (DSA) played a key role in the success of the two weapons systems used by the Navy. The RIM-7 Sea Sparrow is a U.S. ship-borne short-range anti-aircraft and anti-missile weapon system that uses folding wings which allow for more missiles to be loaded into the launcher. The Tomahawk is a long-range, all-weather, subsonic cruise missile.
Working with Navy engineers & scientists, DSA developed two test applications, one that evaluated the performance of the springs used to unfold the wings in the Sea Sparrow missiles and another that was used to test the guidance and navigation systems used by Tomahawk missiles. DSA is proud to be part of keeping U.S. sailors and warships safe. Read more here.
Project Execution Network, a Pittsburgh based startup, has introduced the consulting industry’s first cloud-based, automated IT and business services platform. The platform was built to connect small and midsize businesses with the region’s growing community of experienced independent consultants. Project Execution Network’s platform combines consulting and managed services portals, an online marketplace, a 24/7 network operations center, an analytics toolkit and a professional services automation system.
Project Execution Network re-engineered the consulting business process by combining advanced analytics, cloud-based technologies and experienced resources. The result enables SMBs to achieve strategic clarity and precise execution with 30% less cost, time and complexity vs. legacy consulting methods — on demand. SMBs can acquire the services of individual resources, project teams and complete functional departments, whenever or wherever needed. The scope of professional services offered by Project Execution Network includes information technology, strategy, business planning, digital marketing, sales enablement, operations, human capital management and financial analysis. – 1/2 – For Immediate Release Project Execution Network’s IT capabilities, combined with business process capabilities, optimizes the integration of technology with operations, and the selection and use of cloud-based applications.
The cornerstone of the company’s platform is the IT Department-as-a-Service™ solution, which integrates a 24/7 network operations center, help desk, assessment and planning capabilities, collaboration tools, training center and document management system. The network operations capabilities include 24/7 desktop, server, mobile device, security, and backup/disaster recovery services. The complete family of Department-as-a-Service™ solutions include IT, digital marketing, sales enablement and human capital management.
A recent study published in the electronic issue (October) of the journal Cancer Epidemiology, Biomarkers and Prevention provides further validation to support the clinical use of TissueCypher® Barrett’s Esophagus Assay (TissueCypher®), developed by Cernostics, Inc., a leader in tissue-based diagnostics. Results show that TissueCypher® identifies high risk Barrett’s esophagus (BE) patients who are 46x (odds ratio from the study) more likely to have either high grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) at the time of biopsy vs. BE patients who scored low risk with TissueCypher.1
“This study is an important step forward in our ability to more accurately risk-stratify patients with Barrett’s Esophagus, which will ultimately lead to improved physician decision making, and more optimal surveillance of patients with Barrett’s Esophagus,” stated Dr. Prateek Sharma, Gastroenterologist with the University Of Kansas Medical Center, who was not affiliated with the study.
The study concluded that the tissue systems pathology test (TissueCypher®) better predicts presence of prevalent HGD and EAC in Barrett’s esophagus patients vs. standard pathology testing. TissueCypher demonstrated high accuracy in detecting the presence of prevalent HGD and EAC, even in biopsies with a pathologic diagnosis of non-dysplastic intestinal metaplasia (non-dysplastic Barrett’s Esophagus). Barrett’s Esophagus is a major risk factor for developing HGD and EAC2.
TissueCypher® is the first diagnostic test of its kind that predicts the risk of developing esophageal cancer in patients with Barret’s Esophagus. The technology uses digitally scanned images of a biopsy to measure and analyze cellular and molecular changes that precede structural changes within the tissue.
The study, which was conducted with leading medical institutions; University of Pittsburgh, Geisinger Health System, University of Pennsylvania and the Academic Medical Center, located in Amsterdam, evaluated 175 patients with BE, including 30 patients with confirmed HGD or EAC.